American Heart Journal
Volume 157, Issue 5 , Pages 811-817.e1 , May 2009

Efficacy of Xience/promus versus Cypher in rEducing Late Loss after stENTing (EXCELLENT) trial: Study design and rationale of a Korean multicenter prospective randomized trial

  • Kyung Woo Park, MD

      Affiliations

    • Cardiovascular Center, Seoul National University Main Hospital, Seoul, South Korea
    • ,
  • Jung-Han Yoon, MD

      Affiliations

    • Yonsei University Wonju Severance Hospital, Wonju, South Korea
    • ,
  • Jung-Sun Kim, MD

      Affiliations

    • Yonsei University Severance Hospital, Seoul, South Korea
    • ,
  • Joo-Yong Hahn, MD

      Affiliations

    • Sung-Kyun-Kwan University Samsung Medical Center, Seoul, South Korea
    • ,
  • Young-Seok Cho, MD

      Affiliations

    • Seoul National University Bundang Hospital, Sungnam, South Korea
    • ,
  • In-Ho Chae, MD

      Affiliations

    • Seoul National University Bundang Hospital, Sungnam, South Korea
    • ,
  • Hyeon-Cheol Gwon, MD

      Affiliations

    • Sung-Kyun-Kwan University Samsung Medical Center, Seoul, South Korea
    • ,
  • Taehoon Ahn, MD

      Affiliations

    • Gachon University Gil Medical Center, Incheon, South Korea
    • ,
  • Byung-Hee Oh, MD

      Affiliations

    • Cardiovascular Center, Seoul National University Main Hospital, Seoul, South Korea
    • ,
  • Jeong-Euy Park, MD

      Affiliations

    • Sung-Kyun-Kwan University Samsung Medical Center, Seoul, South Korea
    • ,
  • Won-Heum Shim, MD

      Affiliations

    • Yonsei University Severance Hospital, Seoul, South Korea
    • ,
  • Eak-Kyun Shin, MD

      Affiliations

    • Gachon University Gil Medical Center, Incheon, South Korea
    • ,
  • Yang-Soo Jang, MD

      Affiliations

    • Yonsei University Severance Hospital, Seoul, South Korea
    • Corresponding Author InformationReprint requests: Hyo-Soo Kim, MD, PhD / Yang-Soo Jang, MD, PhD, Department of Internal Medicine and Cardiovascular Center, Seoul National University Hospital/Yonsei University Severance Hospital, 28 Yongon-dong Chongno-gu, Seoul 110-744, South Korea.
    • ,
  • Hyo-Soo Kim, MD

      Affiliations

    • Cardiovascular Center, Seoul National University Main Hospital, Seoul, South Korea
    • Corresponding Author InformationReprint requests: Hyo-Soo Kim, MD, PhD / Yang-Soo Jang, MD, PhD, Department of Internal Medicine and Cardiovascular Center, Seoul National University Hospital/Yonsei University Severance Hospital, 28 Yongon-dong Chongno-gu, Seoul 110-744, South Korea.

Received 16 August 2008 ,Accepted 10 February 2009.

  • Image Result

    EXCELLENT trial algorithm. Target vessel failure defined as the composite of cardiac death, nonfatal MI, and TVR. TLR, Target lesion revascularization.

    EXCELLENT trial algorithm. Target vessel failure defined as the composite of cardiac death, nonfatal MI, and TVR. TLR, Target lesion revascularization.

 ClinicalTrials.gov identifier: NCT00698607.

PII: S0002-8703(09)00134-3

doi: 10.1016/j.ahj.2009.02.008

American Heart Journal
Volume 157, Issue 5 , Pages 811-817.e1 , May 2009

Article Tools

* Image Usage & Resolution